- Filings
- Filing Tables
-
Filing Analysis
- News
- Transcripts
- Patents
GSK
GSK
|
44 | |
Glaxosmithkline Capital Inc
|
8 | |
Glaxosmithkline Capital Inc
|
8 | |
TPTX
Turning Point Therapeutics
|
1 |
20-F | 25 | |
S-8 | 10 | |
F-3 | 6 | |
6-K | 2 | |
SC 13D/A | 1 |